Although delayed diagnosis of EoE presents considerable risk to those with this chronic inflammatory disease, novel treatments are providing hope that a new era is on the horizon.
Regardless of a prior history of swallowed topical corticosteroids, dupilumab was proven to be an effective treatment in patients with eosinophilic esophagitis.
Regardless of a prior history of swallowed topical corticosteroids, dupilumab was proven to be an effective treatment in patients with eosinophilic esophagitis.